🟢 Gain Therapeutics is trading 9.74% up in pre-market

Gain Therapeutics is trading at $1.55, up +9.74% in pre-market, with no clear company-specific catalyst identified.

• The company’s previously announced Maxim Growth Summit participation runs October 12–14; available information does not link it to the move.
• Major indices are up less than 0.5%, which does not establish a broader-market explanation for the move.